Target intelligence / Profile preview

Ferritin heavy chain 1 mRNA (FTH1 mRNA) (FTH1 mRNA)

Target
FTH1 mRNA
Molecular classification
Messenger RNA, RNA
01

Overview

Ferritin heavy chain 1 (FTH1) mRNA encodes the heavy subunit of the ferritin complex, which is the primary intracellular protein responsible for the safe storage of iron (UniProt P02794). The FTH1 protein is characterized by its essential ferroxidase activity, which converts toxic ferrous iron (Fe2+) into the non-toxic ferric form (Fe3+) for sequestration within the ferritin shell (NCBI Gene 2495). The translation of FTH1 mRNA is tightly regulated by a highly conserved iron-responsive element (IRE) in its 5' untranslated region, which binds iron regulatory proteins (IRPs) to modulate protein synthesis based on cellular iron availability. In many cancers, FTH1 mRNA is upregulated to sequester iron and protect cells from ferroptosis, an iron-dependent form of regulated cell death (PMID: 33064981). Consequently, targeting FTH1 mRNA with antisense oligonucleotides or siRNA is being explored as a therapeutic strategy to increase the labile iron pool and sensitize tumor cells to ferroptosis-inducing therapies (PMID: 27572130). Beyond oncology, dysregulation of FTH1 mRNA is linked to neurodegenerative diseases like Alzheimer's and Parkinson's, where iron accumulation contributes to neuronal damage. Therapeutic modulation of this target aims to restore iron balance and mitigate oxidative stress in various pathological contexts.

Other names
Ferritin heavy polypeptide 1 mRNAFTH mRNAFTHL6 mRNAPIG15 mRNAFerritin H-chain mRNA
02

Mechanism of action

Antisense-mediated mRNA degradation or RNA interference to reduce FTH1 protein levels, thereby increasing the intracellular labile iron pool and sensitizing cells to ferroptosis.

03

Biological functions

Iron sequestrationFerroxidase activityIron homeostasisRegulation of ferroptosisOxidative stress protection
04

Disease associations

CancerNeurodegenerative diseaseIron overload disorderInflammation
05

Safety considerations

Systemic iron metabolism disruptionPotential for iron-induced oxidative damage in healthy tissuesOff-target effects on other iron-responsive element (IRE) containing mRNAs
06

Interacting drugs

FTH1-targeting antisense oligonucleotides (experimental)

1 more in the full profile.

07

Biomarkers

FTH1 protein expression levelsLabile iron pool (LIP) concentrationSerum ferritin levelsIntracellular iron levels

Beyond the preview

Go deeper on Ferritin heavy chain 1 mRNA (FTH1 mRNA) (FTH1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferritin heavy chain 1 mRNA (FTH1 mRNA) (FTH1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call